ArticleSignal transduction and targeted therapy2021

Administration of B7-H3 targeted chimeric antigen receptor-T cells induce regression of glioblastoma.

Xin Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.